Nuvalent, Inc. (NUVL)

Latest Insider Confidence Score

2026Q1

43.7
Bearish

Company insider confidence (by quarter)

2021Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Hack Andrew A. F. Director 2,697,267 Mar 29, 2024
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. — 897,671 Aug 3, 2021
Flynn James E Director 650,000 Nov 24, 2025
Deerfield Management Company, L.P. (Series C) Director 650,000 Nov 24, 2025
Deerfield Mgmt HIF, L.P. Director 650,000 Nov 24, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 26, 2026 Mar 2, 2026 Noci Darlene Chief Development Officer Sell 28.8 -5,500 -8.65% ✓ $566.7K
Feb 26, 2026 Mar 2, 2026 Miller Deborah Ann Chief Legal Officer Sell 28.8 -5,500 -8.44% ✓ $566.8K
Jan 29, 2026 Feb 2, 2026 Noci Darlene Chief Development Officer Sell 28.8 -5,500 -8.65% ✓ $561.4K
Jan 21, 2026 Jan 23, 2026 Miller Deborah Ann Chief Legal Officer Sell 23.8 -15,000 -11.17% ✓ $1.7M
Jan 5, 2026 Jan 7, 2026 Pelish Henry E. Chief Scientific Officer Sell 97.5 +12,340 17.37% ✓ $501.8K
Jan 5, 2026 Jan 7, 2026 Noci Darlene Chief Development Officer Sell 97.5 +10,083 20.99% ✓ $721.3K
Jan 5, 2026 Jan 7, 2026 Miller Deborah Ann Chief Legal Officer Sell 97.5 +10,548 21.49% ✓ $676.2K
Jan 5, 2026 Jan 7, 2026 Turner Christopher Durant Chief Medical Officer Sell 97.5 +10,083 16.12% ✓ $721.3K
Jan 5, 2026 Jan 7, 2026 Balcom Alexandra CFO Sell 97.5 +10,083 11.31% ✓ $721.3K
Jan 5, 2026 Jan 7, 2026 Porter James Richard CEO Sell 95.0 +18,817 6.15% ✓ $2.7M
Jan 2, 2026 Jan 5, 2026 Miller Deborah Ann Chief Legal Officer Sell 18.8 -10,000 -16.92% ✓ $1M
Dec 30, 2025 Jan 2, 2026 Noci Darlene Chief Development Officer Sell 28.8 -4,000 -7.69% ✓ $400.2K
Dec 22, 2025 Dec 23, 2025 Pelish Henry E. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 22, 2025 Dec 23, 2025 Balcom Alexandra CFO Neutral 52.5 - 0.00% ✗ -
Dec 19, 2025 Dec 23, 2025 Porter James Richard CEO Neutral 52.5 - 0.00% ✗ -
Dec 10, 2025 Dec 11, 2025 Squarer Ron Director Neutral 90.0 +2,837 100.00% ✗ -
Dec 11, 2025 Squarer Ron Director Neutral 52.5 - 0.00% ✗ -
Dec 8, 2025 Dec 10, 2025 Balcom Alexandra CFO Sell 22.5 -7,084 -11.48% ✓ $781.5K
Nov 28, 2025 Dec 2, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $434.3K
Nov 24, 2025 Nov 26, 2025 Shair Matthew Director Sell 46.3 -7,500 -0.47% ✓ $820.3K
Nov 24, 2025 Nov 24, 2025 Flynn James E Director Sell 15.0 -742,574 -4.13% ✗ $70.9M
Nov 17, 2025 Nov 19, 2025 Balcom Alexandra CFO Sell 32.5 -20,729 -3.71% ✓ $2.1M
Nov 17, 2025 Nov 19, 2025 Miller Deborah Ann Chief Legal Officer Sell 5.0 -24,200 -33.02% ✓ $2.6M
Oct 30, 2025 Oct 31, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $411.7K
Oct 30, 2025 Oct 31, 2025 Miller Deborah Ann Chief Legal Officer Sell 5.0 -21,800 -30.75% ✓ $2.2M
Oct 27, 2025 Oct 29, 2025 Shair Matthew Director Sell 31.3 -60,000 -3.64% ✓ $6M
Oct 20, 2025 Oct 22, 2025 Miller Deborah Ann Chief Legal Officer Sell 26.3 -5,000 -9.24% ✓ $474.6K
Oct 16, 2025 Oct 17, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2.4M
Oct 15, 2025 Oct 17, 2025 Miller Deborah Ann Chief Legal Officer Sell 20.0 -28,000 -11.70% ✓ $2.5M
Oct 15, 2025 Oct 17, 2025 Pelish Henry E. Chief Scientific Officer Sell 15.0 -14,205 -17.72% ✓ $1.3M
Oct 15, 2025 Oct 17, 2025 Balcom Alexandra CFO Sell 41.3 -1,683 -2.65% ✓ $144K
Oct 13, 2025 Oct 15, 2025 Balcom Alexandra CFO Sell 23.8 -40,000 -8.04% ✓ $3.5M
Oct 13, 2025 Oct 15, 2025 Pelish Henry E. Chief Scientific Officer Sell 35.0 -10,070 -3.65% ✓ $894.6K
Oct 1, 2025 Oct 3, 2025 Balcom Alexandra CFO Sell 10.0 -20,000 -24.47% ✓ $1.7M
Sep 29, 2025 Oct 1, 2025 Balcom Alexandra CFO Sell 15.0 -27,588 -18.26% ✓ $2.3M
Sep 29, 2025 Oct 1, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $332.3K
Sep 15, 2025 Sep 17, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2.1M
Sep 10, 2025 Sep 12, 2025 Pelish Henry E. Chief Scientific Officer Sell 30.0 -3,725 -5.35% ✓ $293.6K
Aug 29, 2025 Sep 3, 2025 Pelish Henry E. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 25, 2025 Aug 27, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $298.5K
Aug 15, 2025 Aug 19, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2M
Aug 7, 2025 Aug 8, 2025 Pelish Henry E. Chief Scientific Officer Sell 26.3 -5,500 -8.28% ✓ $411.7K
Jul 30, 2025 Aug 1, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $321.4K
Jul 15, 2025 Jul 17, 2025 Balcom Alexandra CFO Sell 27.5 -20,000 -6.02% ✓ $1.7M
Jul 15, 2025 Jul 17, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2.2M
Jul 9, 2025 Jul 11, 2025 Pelish Henry E. Chief Scientific Officer Sell 35.0 -7,645 -3.03% ✓ $614K
Jun 27, 2025 Jul 1, 2025 Balcom Alexandra CFO Sell 10.0 -20,000 -24.47% ✓ $1.6M
Jun 26, 2025 Jun 27, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $314.8K
Jun 25, 2025 Jun 27, 2025 Pelish Henry E. Chief Scientific Officer Sell 26.3 -10,800 -7.88% ✓ $862.7K
Jun 18, 2025 Jun 20, 2025 Flynn James E Director Neutral 47.5 +5,294 0.03% ✗ -
Jun 18, 2025 Jun 20, 2025 Wheeler Cameron Director Neutral 90.0 +2,647 105.92% ✗ -
Jun 18, 2025 Jun 20, 2025 Srivastava Sapna Director Neutral 90.0 +2,647 105.92% ✗ -
Jun 18, 2025 Jun 20, 2025 Shair Matthew Director Neutral 55.0 +2,647 0.16% ✗ -
Jun 18, 2025 Jun 20, 2025 Protopapas Anna Director Neutral 90.0 +2,647 105.92% ✗ -
Jun 18, 2025 Jun 20, 2025 Pearlberg Joseph Director Neutral 90.0 +2,647 105.92% ✗ -
Jun 18, 2025 Jun 20, 2025 Meyers Michael L. Director Neutral 90.0 +2,647 105.92% ✗ -
Jun 18, 2025 Jun 20, 2025 Bogle Grant C. Director Neutral 90.0 +2,647 82.72% ✗ -
Jun 18, 2025 Jun 20, 2025 Oliger Christy J. Director Neutral 90.0 +3,971 100.00% ✗ -
Jun 20, 2025 Oliger Christy J. Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 17, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2.1M
Jun 6, 2025 Jun 10, 2025 Pelish Henry E. Chief Scientific Officer Sell 52.5 -200 -0.32% ✓ $16K
May 29, 2025 May 30, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $285.2K
May 15, 2025 May 16, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $1.9M
Apr 29, 2025 May 1, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $298.2K
Apr 15, 2025 Apr 17, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $1.9M
Mar 27, 2025 Mar 28, 2025 Noci Darlene Chief Development Officer Sell 26.3 -4,000 -7.69% ✓ $292.5K
Mar 17, 2025 Mar 19, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2M
Mar 6, 2025 Mar 10, 2025 Noci Darlene Chief Development Officer Sell 20.0 -34,000 -11.11% ✓ $2.4M
Feb 24, 2025 Feb 25, 2025 Shair Matthew Director Sell 50.0 -2,000 -0.12% ✓ $156.9K
Feb 18, 2025 Feb 20, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2.1M
Jan 31, 2025 Feb 4, 2025 Pelish Henry E. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 27, 2025 Jan 29, 2025 Shair Matthew Director Sell 50.0 -2,000 -0.12% ✓ $165.6K
Jan 15, 2025 Jan 17, 2025 Porter James Richard CEO Sell 23.8 -27,000 -9.78% ✓ $2.1M
Jan 6, 2025 Jan 8, 2025 Pelish Henry E. Chief Scientific Officer Sell 95.0 +16,267 37.21% ✓ $197.9K
Jan 6, 2025 Jan 8, 2025 Noci Darlene Chief Development Officer Sell 97.5 +14,734 44.25% ✓ $320K
Jan 6, 2025 Jan 8, 2025 Miller Deborah Ann Chief Legal Officer Sell 95.0 +15,786 47.41% ✓ $236.2K
Jan 6, 2025 Jan 8, 2025 Turner Christopher Durant Chief Medical Officer Sell 97.5 +14,734 30.82% ✓ $320K
Jan 6, 2025 Jan 8, 2025 Balcom Alexandra CFO Sell 97.5 +14,734 31.35% ✓ $320K
Jan 6, 2025 Jan 8, 2025 Porter James Richard CEO Sell 100.0 +38,949 18.54% ✓ $1.4M
Dec 23, 2024 Dec 26, 2024 Shair Matthew Director Sell 50.0 -2,000 -0.12% ✓ $167.6K
Dec 19, 2024 Dec 20, 2024 Porter James Richard CEO Neutral 52.5 - 0.00% ✗ -
Dec 17, 2024 Dec 18, 2024 Balcom Alexandra CFO Neutral 52.5 - 0.00% ✗ -
Dec 16, 2024 Dec 18, 2024 Pelish Henry E. Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Dec 16, 2024 Dec 18, 2024 Porter James Richard CEO Sell 20.0 -27,000 -12.55% ✓ $2.3M
Dec 11, 2024 Dec 13, 2024 Hack Andrew A. F. Director Sell 15.0 -1,250,000 -46.30% ✗ $110M
Dec 5, 2024 Dec 9, 2024 Bogle Grant C. Director Neutral 90.0 +3,200 100.00% ✗ -
Dec 9, 2024 Bogle Grant C. Director Neutral 52.5 - 0.00% ✗ -
Nov 29, 2024 Dec 3, 2024 Balcom Alexandra CFO Sell 12.5 -10,000 -23.09% ✓ $957.9K
Nov 25, 2024 Nov 27, 2024 Shair Matthew Director Sell 50.0 -2,000 -0.12% ✓ $192.4K
Nov 15, 2024 Nov 19, 2024 Porter James Richard CEO Sell 20.0 -27,000 -12.55% ✓ $2.4M
Nov 1, 2024 Nov 4, 2024 Noci Darlene Chief Development Officer Sell 22.5 -5,000 -13.05% ✓ $443K
Oct 31, 2024 Nov 4, 2024 Balcom Alexandra CFO Sell 12.5 -10,000 -23.09% ✓ $891.9K
Oct 28, 2024 Oct 30, 2024 Shair Matthew Director Sell 50.0 -2,000 -0.12% ✓ $183.5K
Oct 22, 2024 Oct 24, 2024 Flynn James E Director Sell 15.0 -2,000,000 -10.00% ✗ $195.5M
Oct 15, 2024 Oct 17, 2024 Porter James Richard CEO Sell 20.0 -27,000 -12.55% ✓ $2.8M
Oct 1, 2024 Oct 2, 2024 Noci Darlene Chief Development Officer Sell 22.5 -5,000 -13.05% ✓ $508.7K
Sep 30, 2024 Oct 2, 2024 Balcom Alexandra CFO Sell 10.0 -10,000 -23.09% ✓ $1M
Sep 23, 2024 Sep 25, 2024 Shair Matthew Director Sell 50.0 -2,000 -0.12% ✓ $205.5K
Sep 16, 2024 Sep 18, 2024 Pelish Henry E. Chief Scientific Officer Sell 5.0 -32,795 -49.62% ✓ $3.2M
Sep 16, 2024 Sep 18, 2024 Miller Deborah Ann Chief Legal Officer Sell 17.5 -8,000 -19.37% ✓ $771.8K